B-cell targeting therapy for SLE (Systemic Lupus Erythematous) via blocking BLyS B-lymphocyte stimulator, causing them to undergo apoptosis (cell death) rather than proliferation leading to increased activity of antibody-producing plasma B cells.
Keywords: Airbrush, 3D, Advertising / Marketing, Stock, Web, Cell biology / Histology, Disease Management, Molecular Biology, Neuroscience, Pharmacology
© John W. Karapelou